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H I G H L I G H T S
• Spinal 5-HT3Rs facilitate noxious mechanical sensory transmission in sham rats.
• Spinal 5-HT2AR block reveals minimal tonic activity in sham rats.
• Enhanced descending facilitation of evoked but not spontaneous neuronal activity in SNL rats.
• Cold and heat transmission facilitated via spinal 5-HT2A and 5-HT3Rs respectively in SNL rats.
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A B S T R A C T
Descending brainstem control of spinal nociceptive processing permits a dynamic and adaptive modulation of
ascending sensory information. Chronic pain states are frequently associated with enhanced descending ex-
citatory drive mediated predominantly through serotonergic neurones in the rostral ventromedial medulla. In
this study, we examine the roles of spinal 5-HT2A and 5-HT3 receptors in modulating ascending sensory output in
normal and neuropathic states. In vivo electrophysiology was performed in anaesthetised spinal nerve ligated
(SNL) and sham-operated rats to record from wide dynamic range neurones in the ventral posterolateral tha-
lamus. In sham rats, block of spinal 5-HT3Rs with ondansetron revealed tonic facilitation of noxious punctate
mechanical stimulation, whereas blocking 5-HT2ARs with ketanserin had minimal eﬀect on neuronal responses
to evoked stimuli. The inhibitory proﬁles of both drugs were altered in SNL rats; ondansetron additionally
inhibited neuronal responses to lower intensity punctate mechanical stimuli and noxious heat evoked responses,
whereas ketanserin inhibited innocuous and noxious evaporative cooling evoked responses. Neither drug had
any eﬀect on dynamic brush evoked responses nor on spontaneous ﬁring rates in both sham and SNL rats. These
data identify novel modality and intensity selective facilitatory roles of spinal 5-HT2A and 5-HT3 receptors on
sensory neuronal processing within the spinothalamic-somatosensory cortical pathway.
1. Introduction
Brainstem nuclei and higher brain centres can exert powerful
modulation of nociceptive processing at the spinal level. This bi-di-
rectional control serves to amplify or suppress sensory transmission
depending on context, expectation and emotional state. This is ele-
gantly demonstrated during placebo analgesia, which is in part de-
pendent on descending opioidergic pathways (Eippert et al., 2009). In
addition, a recently identiﬁed bulbospinal projection is implicated in
acute stress-induced hypoalgesia and chronic stress-induced hy-
persensitivity (Francois et al., 2017). Descending modulation is largely
orchestrated via the periaqueductal grey (PAG), locus coeruleus and
rostral ventromedial medulla (RVM) (Ossipov et al., 2014), although
cortical regions such as the cingulate can exert direct facilitatory in-
ﬂuences on spinal excitability (Chen et al., 2018), or indirectly via
cortical-sub-cortical networks engaging descending brainstem path-
ways (Tan et al., 2017).
It is clear parallel inhibitory and excitatory pathways originating
from the RVM exist (Zhuo and Gebhart, 1992). Neurones within the
RVM display distinct ﬁring patterns in response to noxious somatic
stimulation; quiescent ON-cells begin ﬁring and are considered to
mediate descending facilitation, whereas tonically active OFF-cells
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abruptly cease ﬁring and are considered to exert inhibitory inﬂuences
(Fields et al., 1983; Heinricher et al., 1989), and a proportion of these
sub-populations appear to be serotonergic (Gau et al., 2013; Mason,
1997). Numerous lines of evidence indicate facilitatory inﬂuences
predominate. Selective optogenetic activation of medullary ser-
otonergic neurones decreases nociceptive response thresholds (Cai
et al., 2014). Lidocaine block of the RVM or depletion of spinal 5-HT
decreases spinal neuronal excitability consistent with tonic facilitatory
activity in normal states (Bee and Dickenson, 2007; Rahman et al.,
2006). The ablation of NK1+ projection neurones in the dorsal horn
with a saporin-substance P conjugate also suppresses deep dorsal horn
neuronal excitability (Suzuki et al., 2002), revealing the parabrachial-
RVM pathway as the eﬀerent arm of a spino-bulbo-spinal circuit acting
as a positive feedback loop facilitating spinal neuronal responses during
noxious stimulation (Roeder et al., 2016; Suzuki et al., 2002).
Neuropathy and chronic pain states can be associated with in-
creased descending facilitation; this time-dependent change in en-
hanced excitatory drive, and the failure to recruit inhibitory pathways
(De Felice et al., 2011), promotes the transition from acute to chronic
pain states and sustains persistent long-term pain (Burgess et al., 2002;
Okubo et al., 2013; Wang et al., 2013; Wei et al., 2010; You et al.,
2010). However, the precise roles of spinal 5-HTRs in diﬀerent states
have been diﬃcult to characterise due to their complex dual pro- and
anti-nociceptive functions, and the selectivity of available antagonists.
However, we and others have reported key roles of the 5-HT3R in
descending facilitations in a number of pain models (Bannister and
Dickenson, 2016). In this study, we examine whether spinal 5-HT2A and
5-HT3 receptors have intensity-dependent and modality-selective roles
in modulating ascending sensory output, and how these functions are
altered in a neuropathic state. We blocked spinal 5-HT2ARs with ke-
tanserin and 5-HT3Rs with ondansetron, and determined the eﬀects on
sensory neuronal coding in the ventral posterolateral thalamus (VPL).
The STT-VP-S1/2 pathway is a key sensory-discriminative relay, and
wide dynamic range (WDR) neurones in the rat VPL exhibit intensity-
dependent coding across sensory modalities (Patel and Dickenson,
2016). Spinal WDR neurones code sensory inputs in a similar manner to
human psychophysics, and can provide insight into sensory processing
in normal and sensitised states in rodent models (Coghill et al., 1993;
O'Neill et al., 2015; Sikandar et al., 2013b). Furthermore, these neu-
ronal characterisations permit study of drug eﬀects on stimulus in-
tensities and modalities not amenable to behavioural testing in animals.
2. Methods
2.1. Animals
Sham or spinal nerve ligated (14–19 days post-surgery) male
Sprague-Dawley rats (250–300 g) were used for electrophysiological
experiments (Biological Services, University College London, UK).
Animals were group housed (maximum of 4) on a conventional 12 h:
12 h light-dark cycle; food and water were available ad libitum.
Temperature (20–22 °C) and humidity (55–65%) of holding rooms were
closely regulated. All procedures described here were approved by the
UK Home Oﬃce, adhered to the Animals (Scientiﬁc Procedures) Act
1986, and were designed in accordance with ethics guidelines outlined
by the International Association for the Study of Pain (Zimmermann,
1983).
2.2. Spinal nerve ligation (SNL) surgery
SNL surgery was performed as previously described (Ho Kim and
Mo Chung, 1992). Rats (120–130 g) were maintained under 2% v/v
isoﬂurane anaesthesia delivered in a 3:2 ratio of nitrous oxide and
oxygen. Under aseptic conditions a paraspinal incision was made and
the tail muscle excised. Part of the L5 transverse process was removed
to expose the left L5 and L6 spinal nerves, which were then isolated
with a glass nerve hook (Ski-Ry, London, UK) and ligated with a non-
absorbable 6-0 braided silk thread proximal to the formation of the
sciatic nerve. The surrounding skin and muscle was closed with ab-
sorbable 3-0 sutures. Sham surgery was performed in an identical
manner omitting the nerve hook/ligation step. All rats groomed nor-
mally and gained weight in the following days post-surgery. Estab-
lishment of the model was conﬁrmed by determining mechanical
withdrawal thresholds as previously described (Patel et al., 2014) (data
not shown).
2.3. In vivo electrophysiology
Electrophysiology was performed as previously described (Patel
et al., 2018b). Rats were initially anaesthetised with 3.5% v/v iso-
ﬂurane delivered in 3:2 ratio of nitrous oxide and oxygen. Once are-
ﬂexic, a tracheotomy was performed and rats were subsequently
maintained on 1.5% v/v isoﬂurane for the remainder of the experiment
(approximately 4–6 h, core body temperature was regulated with a
homeothermic blanket throughout and respiratory rate was visually
monitored). Rats were secured in a stereotaxic frame, and after the was
the skull exposed, co-ordinates for the right (i.e. contralateral to the
injury) ventral posterolateral thalamus (VPL) were calculated in rela-
tion to bregma (2.28mm caudal, 3.2 mm lateral) (Watson and Paxinos,
2006). A small craniotomy was performed with a high-speed surgical
micro-drill. The muscle overlying the lumbar vertebrae was removed, a
partial laminectomy was performed to expose the L4-L6 lumbar region,
and the overlying dura was removed. Once haemostasis was achieved,
the surrounding muscle was coated in petroleum jelly to form a hy-
drophobic barrier to contain the drug. Extracellular recordings were
made from VPL thalamic neurones with receptive ﬁelds on the glabrous
skin of the left paw hind toes (see Fig. S1 for stereotaxically determined
recording sites) using 127 μm diameter 2MΩ parylene-coated tungsten
electrodes (A-M Systems, Sequim, WA). Searching involved light tap-
ping of the receptive ﬁeld. Neurones in the VPL were classiﬁed as WDR
on the basis of obtaining neuronal responses to dynamic brushing,
noxious punctate mechanical (60 g) and noxious heat stimulation of the
receptive ﬁeld (48 °C). The receptive ﬁeld was then stimulated using a
wider range of natural stimuli (brush, von Frey ﬁlaments – 2, 8, 15, 26
and 60 g and heat – 35, 42, 45 and 48 °C) applied over a period of 10 s
per stimulus. The heat stimulus was applied with a constant water jet
onto the centre of the receptive ﬁeld. Acetone and ethyl chloride
(100 μl) were applied as an evaporative innocuous cooling and noxious
cooling stimulus respectively (Leith et al., 2010). Evoked responses to
room temperature water (25 °C) were minimal, or frequently com-
pletely absent, and subtracted from acetone and ethyl chloride evoked
responses to control for any concomitant mechanical stimulation during
application. Stimuli were applied starting with the lowest intensity
stimulus with approximately 30–40 s between stimuli in the following
order: brush, von Frey, cold, heat.
Baseline recordings were made with 25 μl vehicle (0.9% saline)
applied topically to the dorsal aspect of the spinal cord after aspiration
of any cerebrospinal ﬂuid. After obtaining three baseline responses
(applied in the order described with 5min between each sets of trials,
data were averaged to give control values), the vehicle was removed
and 10 μg and 50 μg ondansetron hydrochloride (Claris Lifesciences,
Cheshire, UK), or 50 μg and 100 μg ketanserin tartrate (Tocris,
Abingdon, UK) were cumulatively applied to the spinal cord in a vo-
lume of 25 μl, and neuronal responses were characterised 20 and
40min post-dosing; time point of peak change from baseline is plotted.
The second dose was applied approximately 50–60min after aspiration
of the ﬁrst dose; excess drug was washed from the cord with 25 μl ve-
hicle (applied for 2–3min). Drug doses were guided by previous studies
(Rahman et al., 2011; Suzuki et al., 2004).
Data were captured and analysed by a CED1401 interface coupled
to a computer with Spike2 v4 software (Cambridge Electronic Design,
Cambridge, United Kingdom) with rate functions. The signal was
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ampliﬁed (x6000), bandpass ﬁltered (low/high frequency cut-oﬀ 1.5/
2 kHz) and digitised at rate of 20 kHz. Spike sorting was performed post
hoc with Spike2 using fast Fourier transform followed by 3-dimensional
principal component analysis of waveform features for multi-unit dis-
crimination. Neurones were recorded from one site per rat; one to three
neurones were characterised at each site. Stimulus evoked neuronal
responses were determined by subtracting total spontaneous neuronal
activity in the 10-s period immediately preceding stimulation.
Spontaneous ﬁring of individual neurones (number of spikes per
second) is expressed as the mean of these 10-s periods. A total of 16
sham and 15 SNL rats were used in this study. All electrophysiological
studies were non-recovery; after the last post-drug time-point, rats were
terminally anesthetised with isoﬂurane.
2.4. Statistics
Statistical analyses were performed using SPSS v25 (IBM, Armonk,
NY). Heat and mechanical coding of neurones were compared with a 2-
way repeated measures (RM) ANOVA, followed by a Bonferroni post hoc
test for paired comparisons. Cold, brush and spontaneous ﬁring were
compared with a 1-way repeated measures (RM) ANOVA, followed by a
Bonferroni post hoc test for paired comparisons. Where appropriate,
sphericity was tested using Mauchly's test; the Greenhouse-Geisser
correction was applied if violated. Group sizes were determined by a
priori calculations (α 0.05, 1-β 0.8). All data represent mean ± 95%
conﬁdence interval (CI). *P < 0.05, **P < 0.01, ***P < 0.001.
3. Results
3.1. Inhibition of spinal 5-HT3 receptors reveals tonic facilitation of noxious
punctate mechanical stimulation in sham rats
Once baseline responses had been obtained (summarised in Table
S1), the 5-HT3R antagonist ondansetron (10 μg and 50 μg) was cumu-
latively applied to the spinal cord. At both doses, ondansetron inhibited
neuronal responses to punctate mechanical stimulation selectively at
the most noxious intensity of stimulation (Fig. 1A) (2-way RM ANOVA,
F2,22= 4.934, P=0.017). The inhibitory eﬀects of ondansetron were
modality selective; no decrease in heat (Fig. 1B) (2-way RM ANOVA,
F2,22= 0.09, P=0.915), innocuous (acetone) and noxious (ethyl
chloride) evaporative cooling (Fig. 1C) (1-way RM ANOVA, acetone:
F2,22= 1.996, P=0.16; ethyl chloride acetone: F2,22= 0.562,
P=0.578), or dynamic brush evoked responses were observed
(Fig. 1D) (1-way RM ANOVA, F2,22= 1.958, P=0.165). In addition,
spinal 5-HT3R block did not aﬀect overall spontaneous ﬁring rates with
only 3/12 units weakly inhibited (Baseline: 9.93 ± 8.68; 10 μg OND:
7.21 ± 6.36; 50 μg OND: 5.09 ± 4.92 spikes s−1) (1-way RM ANOVA,
F1.01,12.09= 1.622, P=0.229).
3.2. Spinal 5-HT3 receptors mediate enhanced facilitation of punctate
mechanical and noxious heat stimuli in SNL rats
The inhibitory proﬁle of spinal ondansetron was altered in neuro-
pathic rats. In contrast to sham-operated rats, in SNL rats 10 μg and
Fig. 1. Eﬀect of spinal 5-HT3 receptor inhibition on stimulus-evoked ﬁring in the VPL of sham rats. WDR neuronal responses to punctate mechanical (A), heat (B),
cold (C), and dynamic brush (D) stimuli, prior to and following spinal administration of ondansetron. Histogram traces represent typical single unit responses. Data
represent mean ± 95% CI, n = 12 neurones from 8 rats. Asterisks (*) denote diﬀerence between baseline and 10 μg ondansetron, daggers (†) denote diﬀerence
between baseline and 50 μg ondansetron, *P < 0.05, **P < 0.01. (Ac – acetone, Ec – ethyl chloride).
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50 μg ondansetron inhibited neuronal responses to lower intensity
punctate mechanical stimuli in addition to the higher intensities
(> 15 g) that may exceed nociceptive withdrawal thresholds (Fig. 2A)
(2-way RM ANOVA, F2,20= 8.472, P=0.0155). Furthermore, noxious
heat evoked neuronal responses were now inhibited at both doses tested
(Fig. 2B) (2-way RM ANOVA, F2,20= 3.61, P=0.046). However, there
were no inhibitory eﬀects on cooling (Fig. 2C) (1-way RM ANOVA,
acetone: F1.2,12.02= 3.312, P=0.089; ethyl chloride acetone:
F2,20= 0.704, P=0.507) or brush evoked responses (Fig. 2D) (1-way
RM ANOVA, F2,20= 2.547, P=0.103). There was no overall eﬀect on
spontaneous activity with only 4/11 units weakly inhibited (Baseline:
14.72 ± 7.27; 10 μg OND: 11.40 ± 5.35; 50 μg OND: 10.09 ± 5.6
spikes s−1) (1-way RM ANOVA, F1.14,11.43= 2.785, P=0.12).
3.3. Inhibition of spinal 5-HT2A receptors reveals minimal tonic facilitatory
inﬂuence in sham rats
After sham rats were dosed spinally with the 5-HT2AR antagonist
ketanserin (50 μg and 100 μg), we found weak evidence for tonic fa-
cilitatory activity in 4/12 units tested in the VPL. However, ketanserin
had no overall eﬀect on neuronal responses to punctate mechanical
stimulation (Fig. 3A) (2-way RM ANOVA, F2,22= 1.232, P=0.311),
heat (Fig. 3B) (2-way RM ANOVA, F2,24= 3.353, P=0.054), cooling
(Fig. 3C) (1-way RM ANOVA, acetone: F1.17,12.85= 0.801, P=0.406;
ethyl chloride acetone: F2,22= 0.716, P=0.5) or brush evoked re-
sponses (Fig. 3D) (1-way RM ANOVA, F2,22= 0.123, P=0.885). In
addition, spinal ketanserin did not alter spontaneous activity in the VPL
(Baseline: 8.69 ± 4.96; 50 μg KTN: 7.66 ± 4.59; 100 μg KTN: 8.70 ±
5.16 spikes s−1) (1-way RM ANOVA, F2,22= 0.791, P=0.466).
3.4. Spinal 5-HT2A receptors mediate enhanced facilitation of cooling
stimuli in SNL rats
The inhibitory proﬁle of spinal ketanserin was also altered in neu-
ropathic rats. As observed in sham rats, there was no overall eﬀect on
punctate mechanical (Fig. 4A) (2-way RM ANOVA, F2,18= 3.22,
P=0.064) and heat evoked responses (Fig. 4B) (2-way RM ANOVA,
F2,18= 1.225, P=0.317). However, both 50 μg and 100 μg ketanserin
inhibited neuronal responses to innocuous (acetone) and noxious (ethyl
chloride) evaporative cooling (Fig. 4C) (1-way RM ANOVA, acetone:
F2,18= 4.595, P=0.024; ethyl chloride acetone: F2,18= 12.391,
P=0.00041). No inhibitory eﬀect was observed on brush evoked re-
sponses (Fig. 4D) (1-way RM ANOVA, F2,18= 0.716, P=0.502), nor on
spontaneous ﬁring rates (Baseline: 18.05 ± 8.32; 50 μg KTN:
18.40 ± 9.22; 100 μg KTN: 15.63 ± 11.26 spikes s−1) (1-way RM
ANOVA, F2,18= 0.36, P=0.703).
4. Discussion
In this study, we describe the intensity and modality selective tonic
pro-nociceptive function of spinal 5-HT2A and 5-HT3 receptors in the
absence of nerve injury, and enhanced facilitatory roles in neuropathic
Fig. 2. Eﬀect of spinal 5-HT3 receptor inhibition on stimulus-evoked ﬁring in the VPL of SNL rats. WDR neuronal responses to punctate mechanical (A), heat (B), cold
(C), and dynamic brush (D) stimuli, prior to and following spinal administration of ondansetron. Histogram traces represent typical single unit responses. Data
represent mean ± 95% CI, n = 11 neurones from 7 rats. Asterisks (*) denote diﬀerence between baseline and 10 μg ondansetron, daggers (†) denote diﬀerence
between baseline and 50 μg ondansetron, *P < 0.05, **P < 0.01, ***P < 0.001. (Ac – acetone, Ec – ethyl chloride).
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conditions. Furthermore, these receptors selectively facilitated sti-
mulus-evoked thalamic neuronal responses but not spontaneous ﬁring
in neuropathic rats. Previous studies often examined descending mod-
ulation of pain utilising spinal endpoints, either behavioural or elec-
trophysiological. The former assay is limited to examining withdrawal
threshold responses and may lack the sensitivity to decipher descending
inﬂuences on spinal excitability given that modulatory medullary
neurones respond selectively to intense noxious stimulation in normal
conditions. Although the latter approach circumvents this shortcoming
and aﬀords the ability to examine neuronal responses to supra-
threshold stimuli, the projection pathways of these neurones are rarely
conﬁrmed and eﬀects on spontaneous neuronal ﬁring are infrequently
studied. To our knowledge, this study for the ﬁrst time examines the
impact of activity within bulbospinal pathways on integrative sensory
processing within the VPL in normal and neuropathic states.
In normal states ON- and OFF-cells in the RVM typically exhibit ‘all-
or-nothing’ responses independently of sensory modality but dis-
criminating between innocuous and noxious inputs. In neuropathic
states, ON-cells gain sensitivity to lower intensity stimuli and display
exaggerated responses to noxious stimulation (Carlson et al., 2007).
Correspondingly, these eﬀects are mirrored at the spinal level following
lidocaine block of the RVM (Bee and Dickenson, 2007). Spinal 5-HTRs
mediate complex pro- and anti-nociceptive eﬀects; in general, 5-HT2A/
3/4Rs are considered to be facilitatory whereas 5-HT1/2C/7Rs are in-
hibitory (Millan, 2002). At the cellular level, 5-HT2A and 5-HT3 re-
ceptors exert excitatory eﬀects, the former via downstream mechanisms
mediated by activation of phospholipase C, whereas the latter is
ionotropic and can directly aﬀect membrane excitability. Anatomically
and functionally, both receptors are implicated in pro- and anti-noci-
ceptive functions. A large number of GABAergic and enkephalinergic
inhibitory interneurons express 5-HT3Rs (Huang et al., 2008), though 5-
HT2AR localisation with GABAergic interneurones is much more limited
(Wang et al., 2009). Both receptors may enhance inhibitory modulation
in the superﬁcial dorsal horn (Fukushima et al., 2009; Xie et al., 2012).
However, numerous studies overwhelmingly support a net facilitatory
role in acute nociceptive, inﬂammatory and neuropathic states (Aira
et al., 2010; Bravo-Hernandez et al., 2012; Cervantes-Duran et al.,
2016; Dogrul et al., 2009; Rahman et al., 2011; Suzuki et al., 2004; Tan
et al., 2017; Zeitz et al., 2002). Pre-synaptically, the 5-HT3R is mainly
expressed in myelinated neurones and low numbers of TRPV1-positive
neurones (Zeitz et al., 2002), and functionally we observe facilitatory
inﬂuences on mechanical but not heat evoked neuronal responses in
sham rats. Although 5-HT3Rs are also present post-synaptically in the
dorsal horn, the modality selective eﬀects are consistent with a pre-
ferential engagement of pre-synaptic receptors by descending ser-
otonergic brainstem projections. Neither block of spinal 5-HT2A nor 5-
HT3 receptors inhibited electrically evoked wind-up of dorsal horn
neurones (Rahman et al., 2011; Suzuki et al., 2004), consistent with a
pre-synaptic locus of action. The 5-HT3R-mediated sensitisation of
TRPV1 in injured and uninjured primary aﬀerent terminals likely leads
to sensitisation to punctate mechanical and heat stimuli in neuropathic
states (Kim et al., 2014). Interactions between 5-HT3R activity and
calcium channel function may also enhance excitatory transmission
(Chang et al., 2013; Suzuki et al., 2005). Neither block of 5-HT2A nor 5-
Fig. 3. Eﬀect of spinal 5-HT2A receptor inhibition on stimulus-evoked ﬁring in the VPL of sham rats. WDR neuronal responses to punctate mechanical (A), heat (B),
cold (C), and dynamic brush (D) stimuli, prior to and following spinal administration of 50 and 100 μg ketanserin. Histogram traces represent typical single unit
responses. Data represent mean ± 95% CI, n=12 neurones from 8 rats. (Ac – acetone, Ec – ethyl chloride).
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HT3 receptors altered dynamic brush-evoked neuronal responses in-
dicating that descending facilitation is unlikely to mediate brush hy-
persensitivity.
We found weak evidence for tonic facilitation of noxious punctate
mechanical and noxious heat evoked responses in sham rats via 5-
HT2ARs, broadly in line with the eﬀects observed on spinal neuronal
excitability (Rahman et al., 2011). In SNL rats, enhanced facilitation of
noxious punctate mechanical and heat responses did not appear to be
mediated through 5-HT2ARs as eﬀect sizes were similar to the sham
group. However, spinal 5-HT2AR block now revealed facilitation of
neuronal responses to innocuous and noxious evaporative cooling. Cold
allodynia is a frequent occurrence in neuropathic conditions (Maier
et al., 2010). Numerous peripheral and spinal mechanisms have been
proposed to underlie this sensory disturbance (Sikandar et al., 2013a),
but altered monoaminergic control should not be overlooked; noxious
cold transmission is modulated by the PAG-RVM pathway in the ab-
sence of injury (Goncalves et al., 2007; Leith et al., 2010), excitability of
RVM ON-cells to somatic cold stimulation is enhanced after nerve in-
jury (Goncalves et al., 2007), and intra-RVM lidocaine reverses beha-
vioural hypersensitivity to cooling in neuropathic rats (Taylor et al.,
2007). The 5-HT2AR can promote excitatory transmitter release in part
by inhibiting 4-amniopyridine sensitive potassium currents (Lambe and
Aghajanian, 2001). In peripheral sensory neurones, transient 4-am-
niopyridine sensitive currents are proposed to set thresholds for cold
sensitivity, and inhibition of this ‘excitatory brake’ could enhance cold
transmission (Viana et al., 2002). Immunoreactivity for 5-HT2ARs is
largely detected in peptidergic and non-peptidergic medium-to-small
sized dorsal root ganglion neurones (Okamoto et al., 2002; Van
Steenwinckel et al., 2009). It does not appear that 5-HT2A and 5-HT3
receptors are upregulated after nerve injury (Hu et al., 2016; Okamoto
et al., 2002; Peters et al., 2010) but enhanced spinal gain may still arise
from a combination of plasticity in descending pathways and spinal
circuits (such as increased 5-HTR coupling to downstream mediators).
Table 1 illustrates the balance between tonic descending inhibitory and
excitatory tone in sham rats, and how this aﬀects thalamic sensory
coding across modalities and stimulus intensity. In neuropathic rats
augmented serotonergic facilitation, and a concurrent loss of des-
cending noradrenergic inhibition (Patel et al., 2018b), contributes to
substantial sensory gain.
Aberrant spontaneous ﬁring of VPL WDR neurones in SNL rats is
dependent on ongoing peripheral and spinal activity (Patel et al.,
2018a). Neither block of spinal 5-HT2A nor 5-HT3 receptors inhibited
spontaneous ﬁring in sham and SNL rats. Consistent with our ob-
servations, following trigeminal nerve injury, depletion of brainstem 5-
HT had no eﬀect on the spontaneous activity of trigeminal nucleus
caudalis neurones (Okubo et al., 2013). However, intrathecal ondan-
setron produces conditioned place preference selectively in neuropathic
rats demonstrating that enhanced serotonergic activity via spinal 5-
HT3Rs can lead to an ongoing aversive state, and supports a partial
separation of sensory and aﬀective processing (Wang et al., 2013).
Polymorphisms of the 5-HT2AR are associated with ﬁbromyalgia, a
condition considered to be dependent on altered central modulation
Fig. 4. Eﬀect of spinal 5-HT2A receptor inhibition on stimulus-evoked ﬁring in the VPL of SNL rats. WDR neuronal responses to punctate mechanical (A), heat (B),
cold (C), and dynamic brush (D) stimuli, prior to and following spinal administration of ketanserin. Histogram traces represent typical single unit responses. Data
represent mean ± 95% CI, n = 10 neurones from 8 rats. Asterisks (*) denote diﬀerence between baseline and 50 μg ketanserin, daggers (†) denote diﬀerence
between baseline and 100 μg ketanserin, *P < 0.05, **P < 0.01. (Ac – acetone, Ec – ethyl chloride).
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(Bondy et al., 1999), and 5-HT3Rs are highly expressed in human dorsal
root ganglion neurones (Ray et al., 2018) supporting involvement of
these receptors in pain modulation in humans. Few clinical reports exist
examining the eﬀect of 5-HT2A antagonists in chronic pain patients. The
5-HT2AR blocker sarpogrelate is not thought to be blood-brain-barrier
permeable but through a peripheral mechanism may provide relief in
diabetic neuropathy (Hotta et al., 1999; Ishimura et al., 1997), and after
lumbar disc herniation (Kanayama et al., 2005). Likewise, the use of
ondansetron clinically for analgesic purposes has been limited due to
the poor penetration of the blood-brain-barrier (Simpson et al., 1992).
In peripheral neuropathy patients, intravenous ondansetron had mixed
eﬀects on ongoing pain (McCleane et al., 2003; Tuveson et al., 2011),
but no eﬀect on brush allodynia (Tuveson et al., 2011), an observation
that resembles the neuronal measure in this study. Similarly, in chronic
back pain patients tropisetron, a highly selective 5-HT3R antagonist,
had no overall eﬀect on the intensity of ongoing pain and minimal ef-
fects on secondary measures of sensitisation (Neziri et al., 2012). Al-
though not considered a neuropathic condition, ﬁbromyalgia is idio-
pathic and is characterised by widespread sensitisation and
musculoskeletal pain, but also disturbances in descending modulation
(O'Brien et al., 2018). Tropisetron was eﬀective in a subgroup of these
patients reducing the number of painful pressure points and associated
pain intensity scores (Farber et al., 2000), and again bears a marked
resemblance to the neuronal measures described here and previously
(Suzuki et al., 2004). Of course, a caveat of these studies is the systemic
route of dosing and the inability to rule out involvement of peripheral
mechanisms or other centrally mediated processes. However, the con-
cordance between the psychophysical measures in ﬁbromyalgia pa-
tients with systemic treatment, and the thalamic neuronal measures
following spinal dosing implies similar underlying processes are tar-
geted.
The modality and intensity dependent facilitatory role the 5-HT3R
supports the notion that 5-HT3R antagonists are more eﬀective for al-
leviating static/punctate mechanical hyperalgesia, and could merit
further clinical investigation in patients stratiﬁed according to these
sensory disturbances. Several have advocated a move to mechanism-
based treatment selection and that sensory proﬁles of patients represent
surrogate measures for underlying mechanisms (Baron et al., 2017;
Bouhassira and Attal, 2016; Max, 1990; Woolf et al., 1998). From a
clinical presentation, determining enhanced descending facilitation as a
mechanism present in a patient poses some diﬃculties. Conditioned
pain modulation (CPM), an assay through which a heterotopic con-
ditioning stimulus inhibits the perceived intensity of a test stimulus,
provides a readout of the integrity of endogenous pain modulation.
CPM is frequently diminished in chronic pain patients (Vaegter and
Graven-Nielsen, 2016; Yarnitsky et al., 2012), but this net loss of in-
hibition might result from decreased noradrenergic inhibitory tone,
increased facilitatory drive, or a combination of both. Baron and col-
leagues describe three sensory phenotypes (‘mechanical’, ‘thermal’ and
‘sensory loss’) in neuropathic patients (Baron et al., 2017), though it is
unclear whether ineﬃcient CPM correlates with any of these. The
sensory proﬁle of the SNL model shares features with the ‘mechanical’
and ‘thermal’ phenotypes (Dickenson and Patel, 2018; Patel et al.,
2018a), and diﬀuse noxious inhibitory controls are absent in this model
(Bannister et al., 2015). Speculatively, based on the modality and in-
tensity dependent roles, enhanced descending facilitation terminating
on 5-HT2A and 5-HT3 receptors may be associated with sub-groups
within the ‘mechanical’ and ‘thermal’ sensory phenotypes; our current
observations could help shape translational pharmacological studies.
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